Injection of Urethral Bulking Agents.
Female stress urinary incontinence
Urethral bulking agents
Urethral injections
Journal
The Urologic clinics of North America
ISSN: 1558-318X
Titre abrégé: Urol Clin North Am
Pays: United States
ID NLM: 0423221
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
entrez:
24
11
2018
pubmed:
24
11
2018
medline:
12
12
2018
Statut:
ppublish
Résumé
Urethral injection is a safe and minimally invasive method of treating female stress urinary incontinence with multiple bulking agents currently commercially available. Although there are numerous studies that demonstrate efficacy, long-term success is not yet proven. This article aims to describe the mechanism of action and properties of various agents, patient selection factors, available techniques for injection, outcomes of urethral injections, and complications associated with the procedure.
Identifiants
pubmed: 30466694
pii: S0094-0143(18)30072-7
doi: 10.1016/j.ucl.2018.08.012
pii:
doi:
Substances chimiques
Acrylic Resins
0
Biocompatible Materials
0
Dimethylpolysiloxanes
0
Gels
0
Glucans
0
Polyvinyls
0
ethylene-vinyl alcohol copolymer
25067-34-9
baysilon
63148-62-9
polyacrylamide
9003-05-8
Hyaluronic Acid
9004-61-9
Collagen
9007-34-5
Durapatite
91D9GV0Z28
Zirconium
C6V6S92N3C
Povidone
FZ989GH94E
Glutaral
T3C89M417N
Dimethyl Sulfoxide
YOW8V9698H
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-15Informations de copyright
Copyright © 2018 Elsevier Inc. All rights reserved.